Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P01CA111412
National Institutes of Health
Grant: R01AR073966
National Institutes of Health
Grant: R01CA203348
National Institutes of Health
Grant: T32HL007741
Basic/Clinical Pilot Research Award, Department of Pharmacology, University of Minnesota
Grant: N/A
NCI NIH HHS
Grant: P01 CA065493
NIGMS NIH HHS
Grant: T32 GM156735
NCI NIH HHS
Grant: R35 CA283892
National Institutes of Health
Grant: 5P01CA111412-04
NK Cells, Their Receptors and Unrelated Donor Transplant
National Institutes of Health
Grant: 5T32HL007741-27
Training in Lung Science
National Institutes of Health
Grant: 3R01AR073966-04S1
Roles of the Src-Family Kinases LynA and LynB in Macrophage Inflammatory Signaling
National Institutes of Health
Grant: 2R01CA203348-06A1
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
FWCI
1.67
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals